Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Norethindrone acetate/Ethinyl Estradiol and Ferrous Fumarate
Overview
What is Larin 24 Fe?
LARIN 24 Fe is a combination oral contraceptive for oral administration consisting of active tablets containing norethindrone acetate, a progestin, and ethinyl estradiol, an estrogen, and placebo tablets containing ferrous fumarate, which serve no therapeutic purpose.
The chemical name of ethinyl estradiol is 19-nor-17 -pregna-1,3,5(10)-trien-20-yne-3,17-diol. The empirical formula of ethinyl estradiol is CHO and the structural formula is:
The chemical name of norethindrone acetate is 17-hydroxy-19-nor-17 -pregn-4-en-20-yn-3-one acetate. The empirical formula of norethindrone acetate is CHO and the structural formula is:
What does Larin 24 Fe look like?
What are the available doses of Larin 24 Fe?
LARIN 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate tablets) is available in blister packs.
Each blister pack (28 tablets) contains in the following order:
What should I talk to my health care provider before I take Larin 24 Fe?
How should I use Larin 24 Fe?
LARIN 24 Fe
The efficacy of in women with a body mass index (BMI) of >35 kg/m2 has not been evaluated. (, )
LARIN 24 Fe is dispensed in a blister card LARIN 24 FE may be started using either a Day 1 start or a Sunday start (see Table 1). For the first cycle of a Sunday Start regimen, an additional method of contraception must be used until after the first 7 consecutive days of administration.
What interacts with Larin 24 Fe?
Sorry No Records found
What are the warnings of Larin 24 Fe?
Sorry No Records found
What are the precautions of Larin 24 Fe?
Sorry No Records found
What are the side effects of Larin 24 Fe?
Sorry No records found
What should I look out for while using Larin 24 Fe?
A high risk of arterial or venous thrombotic diseases
Liver tumors or liver disease
Undiagnosed abnormal uterine bleeding
Breast cancer or other estrogen- or progestin-sensitive cancer
Pregnancy
Co-administration with Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir
What might happen if I take too much Larin 24 Fe?
There have been no reports of serious ill effects from overdose of oral contraceptives, including ingestion by children. Overdosage may cause withdrawal bleeding in females and nausea.
How should I store and handle Larin 24 Fe?
LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].LARIN Fe 1/20 is available in dispensers (NDC 16714-406-01) each containing 21 pale yellow tablets and 7 brown tablets. Each pale yellow, biconvex, round tablet debossed with "L2" on one side contains 1mg of norethindrone acetate and 20 mcg of ethinyl estradiol.Each brown, biconvex, round tablet debossed with "F" on one side and "" on the other side contains 75 mg ferrous fumarate.LARIN Fe 1/20 Tablets are available in the following configurations:Carton of 1 NDC 16714-406-02Carton of 3 NDC 16714-406-03Carton of 6 NDC 16714-406-04Store at 20 ˚ C ~ 25˚ C (68˚ F~77 ˚ F) [See USP Controlled Room Temperature].
Clinical Information
Chemical Structure
No Image foundClinical Pharmacology
COCs lower the risk of becoming pregnant primarily by suppressing ovulation. Other possible mechanisms may include cervical mucus changes that inhibit sperm penetration and endometrial changes that reduce the likelihood of implantation.
Non-Clinical Toxicology
A high risk of arterial or venous thrombotic diseasesLiver tumors or liver disease
Undiagnosed abnormal uterine bleeding
Breast cancer or other estrogen- or progestin-sensitive cancer
Pregnancy
Co-administration with Hepatitis C drug combinations containing ombitasvir/paritaprevir/ritonavir, with or without dasabuvir
ACE-inhibitors:
Aspirin
Thrombotic Disorders and Other Vascular Problems: Stop if a thrombotic event occurs. Stop at least 4 weeks before through 2 weeks after major surgery. Start no earlier than 4 weeks after delivery, in women who are not breastfeeding.
Liver disease: Discontinue if jaundice occurs.
High blood pressure: If used in women with well-controlled hypertension, monitor blood pressure and stop if blood pressure rises significantly.
Carbohydrate and lipid metabolic effects: Monitor prediabetic and diabetic women taking . Consider an alternative contraceptive method for women with uncontrolled dyslipidemia.
Headache: Evaluate significant change in headaches and discontinue if indicated.
Bleeding Irregularities and Amenorrhea: Evaluate irregular bleeding or amenorrhea.
Reference
This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"
While we update our database periodically, we cannot guarantee it is always updated to the latest version.
Review
Professional
Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72Tips
Tips
Interactions
Interactions
A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).